Swine origin influenza (swine flu)

Special Article


Swine origin influenza was first recognized in the border area of Mexico and United States in April 2009 and during a short span of two months became the first pandemic. The currently circulating strain of swine origin influenza virus of the H1N1 strain has undergone triple reassortment and contains genes from the avian, swine and human viruses. It is transmitted by droplets or fomites. Incubation period is 2 to 7 days. Common clinical symptoms are indistinguishable by any viral respiratory illness, and include fever, cough, sore throat and myalgia. A feature seen more frequently with swine origin influenza is GI upset. Less than 10% of patients require hospitalization. Patients at risk of developing severe disease are - younger than five years, elderly, pregnant women, with chronic systemic illnesses, adolescents on aspirin. Of the severe manifestations of swine origin influenza, pneumonia and respiratory failure are the most common. Unusual symptoms reported are conjunctivitis, parotitis, hemophagocytic syndrome. Infants may present with fever and lethargy with no respiratory symptoms. Diagnosis is based on RT PCR, Viral culture or increasing neutralizing antibodies. Principle of treatment consist of isolation, universal precautions, good infection control practices, supportive care and use of antiviral drugs. Antiviral drugs effective against H1N1 virus include: oseltamivir and zamanavir. With good supportive care case fatality is less than 1%. Preventive measures include: social distancing, practicing respiratory etiquette, hand hygiene and use of chemoprohylaxis with antiviral drugs. Vaccine against H1N1 is not available at present, but will be available in near future.

Key words

H1N1 influenza Swine flu Swine origin H1N1 influenza 


  1. 1.
    Kilbourne ED. Influenza pandemics of the 20th century. Emerging Infect Dis 2006; 12: 9–14.PubMedGoogle Scholar
  2. 2.
    Taubenberger JK. The origin and virulence of the 1918 “Spanish” influenza virus. Proc Am Philos Soc 2006; 150: 86–112.PubMedGoogle Scholar
  3. 3.
    Chang LY, Shih SR, Shao PL, Huang DT, Huang LM. Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. J Formos Med Assoc 2009; 108: 526–532.CrossRefPubMedGoogle Scholar
  4. 4.
    Olsen CW. The emergence of novel swine influenza viruses in North America. Virus Res 2002; 85:199–210.CrossRefPubMedGoogle Scholar
  5. 5.
    Myers PK, Olsen CW, Gray CG. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 2007; 44: 1084–1088.CrossRefPubMedGoogle Scholar
  6. 6.
    Laboratory-confirmed cases of pandemic (H1N1) 2009 as officially reported to WHO by States Parties to the IHR (2005) as on 6 August 2009. World Health Organisation: Global alert and response. 12 Aug 2009. http://www.who.int/csr/don/2009_08_12/en/index.html.
  7. 7.
    Centers for Disease Control and Prevention. Novel H1N1 Flu: Facts and Figures. http://cdc.gov/h1n1flu/surveillanceqa.htm
  8. 8.
    Ministry of Health and Family Welfare. Government of India. Influenza A [H1N1] - Status as on 17th August, 2009. http://mohfw.nic.in/Status%20as%20on%2017th%20August%202009.doc
  9. 9.
    Dolin R. Influenza. In, Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson LJ (Eds). Harrisson’s principles of internal medicine. McGraw Hill 2005. Pp 1066–1070.Google Scholar
  10. 10.
    Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus. NEJM 2009; 361: 225–229.CrossRefPubMedGoogle Scholar
  11. 11.
    Glezen WP. Influenza viruses. In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SL, eds. Textbook of Pediatric Infectious Diseases. Saunders. Philadelphia, 2004; 2024–2040.Google Scholar
  12. 12.
    Newman AP, Reisdorf E, Beinemann J, Uyeki TM, Balish A, Shu B, Lindstrom S, Achenbach J, Smith C, Davis JP. Swine influenza A (H1N1) triple reassortant virus infection, Wisconsin. Emerging Infectious Diseases 2008; 14: 1470–1472.CrossRefPubMedGoogle Scholar
  13. 13.
    Interim guidance on antiviral recommendations for patients with novel Influenza A (H1N1) virus infection and their close contacts. Centre for disease control and prevention:H1N1 guidance 6 May 2009. http://www.cdc.gov/h1n1flu/recommendations.htm.
  14. 14.
    Ministry of Health and Family Welfare, Government of India. Swine Flu- Clinical Management Protocol and Infection Control Guidelines. http://mohfw.nic.in/Clinical%20Management-Swine%20Flu.doc
  15. 15.
    Sreta D, Kedkovid R, Tuamsang S, Kitikoon P, Thanawongnuwech R. Pathogenesis of swine influenza virus (Thai isolates) in weanling pigs: an experimental trial. Virology J 2009; 6: 34.CrossRefGoogle Scholar
  16. 16.
    Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. NEJM 2009; 360: 2605–2615.Google Scholar
  17. 17.
    Perez-Padilla R, de la Rosa-Zamboni D, de Leon SP, et al for the INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. NEJM 2009; 361Google Scholar
  18. 18.
    Clinical management of human infection with new influenza A (H1N1) virus: initial guidance. World Health Organisation: Global alert and response. 21 May 2009. http://www.who.int/csr/resources/publications/swineflu/clinical_management/en/index.html
  19. 19.
    Shinde V, Bridges CB, Uyeki TM et al. Triple reassortant swine influenza A (H1) in humans in the United States, 2005–2009. NEJM 2009; 360: 2616–2625.CrossRefPubMedGoogle Scholar
  20. 20.
    Bastien N, Bowness D, Burton L et al. Parotitis in a child 2007. J Clin Microbiol 2009; 47: 1896–1898.CrossRefPubMedGoogle Scholar
  21. 21.
    Hayase Y, Tobita K. Influenza virus and neurological disease. Psych Cin Neurosc 2008; 51: 181–184.CrossRefGoogle Scholar
  22. 22.
    Poser CM. Neurological complications of swine influenza vaccine. Acta Neurol Scan 1981; 44: 413–431.Google Scholar
  23. 23.
    Interim WHO guidance for the surveillance of human infection with swine influenza A(H1N1) virus. World Health Organisation: Global alert and response. 10 July 2009. http://www.who.int/csr/resources/publications/swineflu/interim_guidance/en/index.html.
  24. 24.
    Poon LLM, Chan KH, Smith GJ, Leung CSW, Guan Y, Yuen KY, Peiris JSM. Molecular detection of a novel human influenza (H1N1) of pandemic potential by conventional and Real-Time Quantitative RT-PCR assays. Clin Chem 2009; 55: 1555–1558.CrossRefPubMedGoogle Scholar
  25. 25.
    Ginocchio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009; 45: 191–195.CrossRefPubMedGoogle Scholar
  26. 26.
    Anonymous. Evaluation of Rapid Influenza Diagnostic Tests for Detection of Novel Influenza A (H1N1) Virus - United States, 2009. MMWR 2009: 58; 826–829.Google Scholar
  27. 27.
    Ellis C, McEwen R. Who should receive Tamiflu for swine flu? BMJ 2009; 339: b2698.CrossRefPubMedGoogle Scholar
  28. 28.
    Shun-Shin M, Thompson M, Heneghan C, Perera R, Harnden A, Mant D. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials. BMJ 2009; 339: b3172.CrossRefPubMedGoogle Scholar
  29. 29.
    Mossong J, Opp M, Gerloff N, et al. Emergence of oseltamivir-resistant influenza A H1N1 virus during the 2007–2008 winter season in Luxembourg: clinical characteristics and epidemiology. Antiviral Res 2009 Aug 6. [Epub ahead of print]Google Scholar
  30. 30.
    Dharan NJ, Gubareva LV, Meyer JJ, et al. Oseltamivir-Resistance Working Group. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 2009; 301:1034–1041.CrossRefPubMedGoogle Scholar
  31. 31.
    Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP). Novel H1N1 Vaccination Recommendations. http://cdc.gov/h1n1flu/vaccination/acip.htm
  32. 32.
    Advice on the use of masks in the community setting in Influenza A (H1N1) outbreaks. World Health Organisation: Global alert and response. 3 May 2009. http://www.who.int/csr/resources/publications/Adviceusemasks community revised.pdf
  33. 33.
    Pandemic influenza prevention and mitigation in low resource communities. World Health Organisation: Global alert and response. 2 May 2009. http://www.who.int/csr/resources/publications/swineflu/low_resource_measures/en/index.html
  34. 34.
    Nuno M, Chowell G, Gumel AB. Assessing the role of basic control masures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands. J R Soc Interface 2007; 4: 505–521.CrossRefPubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2009

Authors and Affiliations

  • Meghna R. Sebastian
    • 1
  • Rakesh Lodha
    • 1
  • S.K. Kabra
    • 1
  1. 1.Department of PediatricsAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations